ScinoPharm Taiwan Ltd

Common Name
ScinoPharm Taiwan
Country
Taiwan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
N/A
Ticker
1789
Exchange
TAIWAN STOCK EXCHANGE
Description
Scinopharm Taiwan Ltd. operates as a specialized pharmaceutical company that focuses on the research, development, and manufacture of active pharmaceutical ingredients (APIs). Known for its strong emp...

ScinoPharm Taiwan's Climate Target Data Preview

As of 2023, ScinoPharm Taiwan has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into ScinoPharm Taiwan ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
2024

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into ScinoPharm Taiwan's Greenhouse Gas Emissions Pathways

As of 2023, ScinoPharm Taiwan has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.

Want Full Access to ScinoPharm Taiwan's Climate Targets Dataset?
Sign Up